This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Second Look: Understanding the use of AI Smart Cameras for the diagnosis of Diabetic Retinopathy

Ticker(s): EYENUK, NINOY, OPOSF

Who's the expert?

Institution: The Eye Associates

  • Ophthalmologist and retina specialist at The Eye Associates and Medical Director for the Macular Degeneration Association (MDA). 
  • Diagnosis 300 patients a month with Diabetic Retinopathy.
  • Currently manages 400 patients with demodex blepharitis and prescribes XDEMVY.
  • Clinical Interest in new treatments for wet macular degeneration, diabetic retinopathy, and uveitis.

Interview Questions
Q1.

Please describe your background and practice setting

Added By: ben_admin
Q2.

How many diabetic retinopathy diagnosis do you make monthly?

Added By: ben_admin
Q3.

Can you provide an overview of the diagnosis process? Is imaging always required for an accurate diagnosis?

Added By: ben_admin
Q4.

What is your opinion of the Topcon NW400 camera?

Added By: ben_admin
Q5.

Do you currently utilize AI software for DR diagnosis?

Added By: ben_admin

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.